UK Innovation & Science Seed Fund News

Coventry, UK, 19th July 2021 / NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeutic modalities, has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and existing investor M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. Previous investors BioCity (now We are Pioneer […]

read more

Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes, and guide possible use of drug therapy, to delay the onset of disease symptoms 23 June 2021: Piscataway, New Jersey; Oxford and Manchester, UK. Today, Infinity BiologiX, LLC (IBX) and Cytox Ltd, announce a collaboration to provide a new, non-invasive, […]

read more

London, UK, 21st June 2021 – UKRI has provided a £10million funding boost to the UK Innovation and Science Seed Fund (UKI2S), supporting early-stage businesses arising from world-class scientific research in the UK. UKI2S is a £37million seed fund that invests in early-stage, high-risk, long-term capital for high potential, early-stage businesses.  It aims to boost […]

read more

1 2 3 4 40